Mount Sinai Liver Cancer Program 21st Anniversary Liver Cancer: Breakthroughs and New Therapies

Add to Calendar Mount Sinai Liver Cancer Program 21st Anniversary Liver Cancer: Breakthroughs and New Therapies 11/20/2026 8:30:00 AM 11/20/2026 5:00:00 PM America/New_York For More Details: https://mssm.cloud-cme.com/LiverCancer2026 Description: This conference will assemble multidisciplinary experts on chronic liver diseases, hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) from the Mount Sinai Liver Cancer Program and one outstanding invited lecturer. The meeting aims to provide a summary of the state-of ¬the-art knowledge of the novel advancements reported in 2025 on the pathogenesis and clinical management of liver cancer, including the research... 1470 Madison Avenue, Davis Auditorium false MM/DD/YYYY


Date & Location
Friday, November 20, 2026, 8:30 AM - 5:00 PM, 1470 Madison Avenue, Davis Auditorium, New York, NY

Target Audience
Specialties - Academic/Research, Gastroenterology, Hematology, Hepatology, Interventional Radiology, Liver Diseases, Medical Education, Oncology, Radiation Oncology, Surgeon

Course Overview
This conference will assemble multidisciplinary experts on chronic liver diseases, hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) from the Mount Sinai Liver Cancer Program and one outstanding invited lecturer. The meeting aims to provide a summary of the state-of ¬the-art knowledge of the novel advancements reported in 2025 on the pathogenesis and clinical management of liver cancer, including the research conducted in Mount Sinai. Results of new RCT reported this year that will change the clinical practice will be reviewed.

Objectives
  1. Define the molecular pathogenesis and targeted therapies in liver cancer.
  2. Discuss the role of surgical and loco-regional therapies for liver cancer.
  3. Update the current AASLD proposed standard of management for advanced HCC with new immune combination therapies.
  4. Describe cutting-edge research in liver cancer, highlighting new insights into the pathogenesis of the disease and new molecular and immune therapies, conducted at the Mount Sinai Liver Cancer Program-2025-26

Registration

Registration Types

Registration Fees

Physicians

$50.00

Industry Reps

$100.00

Allied Health Professionals

$50.00

Trainees, Students, Residents, Postdocs, Fellows

$25.00

Mount Sinai Health System

Complimentary



Cancellation Policy
All refund and cancellation requests must be emailed to the CME office at [email protected] by Friday, November 13, 2026. Cancellations after this date are not eligible for a refund. An administrative fee of $50 will be deducted from your refund. No refunds will be issued for registration fees that are equal or less than $50.


Accreditation

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


Credits
AMA PRA Category 1 Credits™ (5.75 hours), Non-Physician Attendance (5.75 hours)

Keywords: LIVE